Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia (Suttorp M et al. Cancers(Basel), February 2021)

Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia
Suttorp M et al. Cancers(Basel), February 2021 - open access publication

Link to full abstract

 


 

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China (Cai Y et al. Int J Hematol, January 2021)

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China
Cai Y et al. Int J Hematol, January 2021 (epub ahead of print)

Link to full abstract

 


 

Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry (Meral Günes A et al. Pediatr Blood Cancer, October 2020)

Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry
Meral Günes A et al. Pediatr Blood Cancer, October 2020

Link to full abstract

 


 

Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML (Chatterjee G et al. J Pediatr Hematol Oncol, January 2021)

Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML
Chatterjee G et al. J Pediatr Hematol Oncol, January 2021

Link to full abstract

 


 

Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study (Meyran D et al. Eur J Cancer, August 2020)

Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study
Meyran D et al. Eur J Cancer, August 2020 (epub ahead of print)

Link to full abstract

 


 

  1. A case of childhood blastic phase chronic myeloid leukemia with minor BCR-ABL (Yamanaka J et al. J Pediatr Hematol Oncol, August 2020)
  2. Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation (Sazawal S et al. Indian J Cancer, July - Sept 2020)
  3. Outcomes of children with chronic myeloid leukemia: A population-based cohort study (Egan G et al. Pediatr Blood Cancer, July 2020)
  4. Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation and the effects on growth in a child with CML: not always a short story (Triche L et al. Pediatr Hematol, Oncol, August 2020)